NDC 0517-9305

Tralement

Trace Elements Injection 4

Tralement is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by American Regent, Inc.. The primary component is Zinc Sulfate; Cupric Sulfate; Manganese Sulfate; Selenious Acid.

Product ID0517-9305_00f9d21e-cdcf-4de5-aecc-4c4c3de50353
NDC0517-9305
Product TypeHuman Prescription Drug
Proprietary NameTralement
Generic NameTrace Elements Injection 4
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2020-09-29
Marketing CategoryNDA / NDA
Application NumberNDA209376
Labeler NameAmerican Regent, Inc.
Substance NameZINC SULFATE; CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID
Active Ingredient Strength3 mg/mL; mg/mL; ug/mL; ug/mL
Pharm ClassesCopper Absorption Inhibitor [EPC],Decreased Copper Ion Absorption [PE],Magnetic Resonance Contrast Activity [MoA],Paramagnetic Contrast Agent [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0517-9305-25

25 VIAL, SINGLE-DOSE in 1 TRAY (0517-9305-25) > 1 mL in 1 VIAL, SINGLE-DOSE (0517-9305-01)
Marketing Start Date2020-09-29
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Tralement" or generic name "Trace Elements Injection 4"

NDCBrand NameGeneric Name
0517-9305TralementTrace Elements Injection 4
0517-9302MultrysTrace Elements Injection 4

Trademark Results [Tralement]

Mark Image

Registration | Serial
Company
Trademark
Application Date
TRALEMENT
TRALEMENT
88181165 not registered Live/Pending
Luitpold Pharmaceuticals, Inc.
2018-11-05

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.